Predictive factors for Enterococcus faecalis in complicated community-acquired urinary tract infections in older patients

Geriatr Gerontol Int. 2020 Mar;20(3):183-186. doi: 10.1111/ggi.13856. Epub 2019 Dec 25.

Abstract

Aim: Risk factors for complicated community acquired Enterococcus faecalis urinary tract infection (UTI) in older patients are not well known.

Methods: We identified the predictive factors for E. faecalis on a cohort of 659 older patients admitted to hospital with complicated UTI. We also examined the adequacy of empirical antimicrobial therapy and outcomes in E. faecalis UTI. Multivariable logistic regression was used to identify predictors of E. faecalis UTI.

Results: A total of 87 (13.2%) patients had E. faecalis UTI; of these 63.2% were men, their mean age was 82.3 years and they had a great number of comorbidities. Severe sepsis or septic shock was present in 50.5%, and bacteremia was present in 26%. Indwelling urinary catheter and previous urinary instrumentation were risk factors for E. faecalis UTI by multivariate analysis (OR 2.05; 95% CI 1.15-3.65 and OR 2.16; 95% CI 1.08-4.34, respectively). Inadequate empirical antimicrobial therapy was higher in E. faecalis UTI than in UTI caused by Gram-negative microorganisms (66.6% vs 19%, P < 0.001). No significant differences in length of hospital stay or mortality were noted between E. faecalis and Gram-negative UTI.

Conclusions: In older patients admitted to hospital with complicated community-acquired UTI, E. faecalis should be considered for empirical treatment if the patient has a urinary catheter or previous urinary tract instrumentation in order to avoid inadequate empirical antibiotic therapy. Geriatr Gerontol Int 2019; ••: ••-••.

Keywords: Enterococcus faecalis; adequacy of empirical therapy; community acquired infections; elderly people; urinary sepsis.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / therapeutic use*
  • Bacteremia / drug therapy*
  • Cohort Studies
  • Community-Acquired Infections
  • Enterococcus faecalis / drug effects*
  • Female
  • Gram-Positive Bacterial Infections / drug therapy
  • Hospitalization
  • Humans
  • Male
  • Prospective Studies
  • Risk Factors
  • Urinary Catheters / adverse effects
  • Urinary Tract Infections / drug therapy*
  • Urinary Tract Infections / microbiology

Substances

  • Anti-Bacterial Agents